Eikon Therapeutics, Inc. Common Stock
Status: Publicly traded
Direct answer
Eikon Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker EIKN.
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes...
Can you invest in Eikon Therapeutics, Inc. Common Stock?
Yes. Eikon Therapeutics, Inc. Common Stock trades publicly on NASDAQ as EIKN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Eikon Therapeutics, Inc. Common Stock
Detailed equity research is provided by MarketSnap.